Monday 7th November 2022

Government Must Act on Cost of Living to Protect Health of Millions With Raynaud's, Says SRUK

SRUK Survey highlights the devastating impact of the cost-of-living crisis and high energy bills for people with Raynaud's.

Read Article

Friday 4th November 2022

RAIRDA Report - Resetting the Balance

The Rare Autoimmune Rheumatic Disease Alliance (RAIRDA) which SRUK is a member of, has released a report highlighting ‘alarming disparities in the quality of care and treatment’ received by people living with rare autoimmune rheumatic diseases (RAIRDs).

Read Article

Monday 10th October 2022

Winter Vaccinations: Get Your COVID-19 Boosters & Flu Vaccines Now!

To help protect those at risk from COVID-19 & flu, the NHS is currently offering flu vaccines and an autumn COVID booster to those with weakened immune systems, the over 50s, and household members of those who are deemed clinically vulnerable. These vaccines can reduce your chances of catching the viruses and getting seriously ill as a result of them. It's as important as ever to make sure that you, and those in close contact to you, are protected from infection before winter rolls around, so read more about how to get both vaccines here!

Read Article

Wednesday 5th October 2022

Reducing Uncertainty in the Progression of Lung Fibrosis in Scleroderma Patients

Having scleroderma often means living with uncertainty around how the disease will progress over time, and the effect that this could have on future quality of life. New research funded by SRUK aims to help address the impact of this ‘prognostic uncertainty’, by using indicators that will predict disease progression and ultimately improve treatment options.

Read Article

Tuesday 20th September 2022

From cancer to autoimmunity: Could CAR T cell therapy cure scleroderma?

CAR T cells are an exciting and emerging therapy which have been used to treat certain cancers, giving hope to those for whom no other treatments have worked. A recent study carried out in Germany which studied patients with lupus suggests that this therapy could be of use in treating a host of autoimmune conditions including scleroderma.

Read Article

Wednesday 14th September 2022

Oral and Dental Problems in Scleroderma: New SRUK-Funded Research Aims to Improve Pathways to Oral Care

Exciting new research run by Professor Liz Walker at the University of Hull and the University of Leeds is aiming to improve oral and dental outcomes for people living with scleroderma, by improving pathways to oral care. You can now get involved in the research team’s study by filling out their short survey about your perspectives on dental and oral care in scleroderma. Find the link on this page!

Read Article

Friday 9th September 2022

Evusheld Survey: New treatment to prevent COVID-19 infection in people with poor immune systems

Do you have scleroderma and have a weakened immune system? Would you like to have your say on whether a treatment which can prevent COVID-19 infection is made available to those who have poor immune responses in response to COVID-19 vaccination? Complete our short survey to inform our response to a NICE consultation on whether this treatment should be authorised for use.

Read Article

Wednesday 7th September 2022

Helping demystify multi-organ fibrosis: The DEMISTIFI study

Would you like to find out more about a new study that aims to improve how we understand and treat fibrosis?

Read Article

Tuesday 9th August 2022

The Decode Scleroderma Study

72 people have signed up for this new trial for people living with diffuse scleroderma and now this clinical study, to test a new investigational drug for use in Diffuse Scleroderma, is ready to start.

Read Article

Monday 1st August 2022

SRUK supports the call on the UK Government to provide Evusheld - a preventative antibody treatment for COVID-19

Evusheld is an antibody treatment designed to prevent patients from contracting COVID-19, and can provide protection for immunocompromised and immunosuppressed people that haven’t mounted a proper response to the vaccine. SRUK is supporting the call for the UK Government to procure and provide Evusheld to patients in the UK. Find out about how you can help on this page.

Read Article